If you need a more accessible version of this website, click this button on the right. Switch to Accessible Site

WARNING

You are using an outdated browser. Please upgrade your browser to improve your experience.

Close [x]

Spinal Decompression Research

Peripheral Neuropathy Research

Spinal Decompression Research

MRI Evidence Of Nonsurgical, Mechanical Reduction, Rehydration And Repair Of The Herniated Lumbar Disc. Edward L. Eyerman, M.D.; Journal of Neuroimaging Vol. 8, No.2; April 1998

Outcomes After a Prone Lumbar Traction Protocol for Patients With Activity-Limiting Low Back Pain: A Prospective Case Series Study
Paul F. Beattie, PhD, PT, OCS, Roger M. Nelson, PhD, PT, Lori A. Michener, PhD, PT, ATC, SCS, Joseph Cammarata, DC,  Jonathan Donley, DPT
Archives of Physical Medicine And Rehabilitation, Volume 89, February 2008

Short And Long-Term Outcomes Following Treatment with the VAX-D Protocol for Patients with Chronic, Activity Limiting Low Back Pain
Beattie PF., Nelson R., Michener L., Cammarata J., Donely J.
Journal of Orthopaedic & Sports Physical Therapy, Volume 35, Number 1, January 2005

Efficacy of Vertebral Axial Decompression (VAX-D) on Chronic Low Back Pain:  A Study of Dosage Regimen
Ramos G., MD
Journal of Neurological Research, Volume 26, April 2004

Effects of Vertebral Axial Decompression On Intradiscal Pressure.
Ramos G., MD, Martin W., MD
Journal of Neurosurgery 81: 350-353, 1994

A Prospective Randomized Controlled Study of VAX-D and TENS for the Treatment of Chronic Low Back Pain
Sherry E., MD FRACS, Kitchener P., MB, BS FRANZCR, Smart R., MB, Ch.B
Journal of Neurological Research Volume 23, No 7, October 2001

Vertebral Axial Decompression Therapy for Pain Associated with Herniated or Degenerated Discs or Facet Syndrome:  An Outcome Study
Gose E., Ph.D, Naguszewski W., MD, Naguszewski R., MD,
Journal of Neurological Research, Volume 20, No 3, April 1998.

Dermatosomal Somatosensory Evoked Potential Demonstration of Nerve Root Decompression After VAX-D Therapy
Naguszewski W., MD, Naguszewski R., MD, Gose E., Ph.D
Journal of Neurological Research Vol 23 , No 7, October 2001

The Effects of Vertebral Axial Decompression On Sensory Nerve Dysfunction In Patients with Low Back Pain and Radiculopathy
Tilaro F., MD, Miskovich D. MD
Canadian Journal of Clinical Medicine Vol. 6, No 1, January 1999

VAX-D Reduces Chronic Discogenic Low Back Pain - 4 year Study
Odell R., MD, Ph.D,  Boudreau D. DO
Anesthesiology News, Volume 29, Number 3 , March 2003

Prospective Randomized Study of VAX-D Therapy for Acute Low Back Distress
Peerless S., MD, FRCP, Meissner L., MD, FRCP
Barnett H. J.M., MD, FRCP, Stiller C. R., MD, FRCP
The John P. Robarts Institute, University Hospital at London
University of Western Ontario, Canada

An Industry Based, Retrospective, Cost Analysis of Vertebral Axial Decompression (VAX-D) VS. Surgery For Lumbar Disc Disease:  10 Case Studies
David C. Duncan, MD, Don Keenan, SPHR, Ph.D.
Sinclair Oil Corporation Study, Tulsa Oklahoma

An Overview of Vertebral Axial Decompression
Tilaro F., MD
Canadian Journal of Clinical Medicine Vol. 5, No 1, January 1998

Articles

Vertebral Axial Decompression
European Musculoskeletal Review 2007 ; Issue 2

Orthopaedics: New answers to an age-old problem.
Hospital Management International 2004; 
Annual Issue of the International Hospital Federation Journal, March 1, 2004

Welcome Relief for Low Back Pain
Stewart J. CBS Health Watch
Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School

Back Pain Abhors a Vacuum
Panko R.,
Best’s Review- Life / Health; A.M. Best Company, Insurance Issues and Analysis, September 1998

The Treatment of Discogenic Low Back Pain: An Integrated Approach (VAX-D- Vertebral Axial Decompression Therapy)
Tilaro F., MD
The McKenzie North American Conference, June 2-4 2000

VAX-D Outcome Study Results
Medical Technologies Group Newsletter
Advisors to the Insurance Industry
Volume 5, Number 15, November 1996

MTG ‘s Special Report On VAX-D
Medical Technologies Group Newsletter
Advisors to the Insurance Industry
Volume 4, Number 8, August 1995

The following links will connect you to a variety of research papers and articles on non-surgical spinal decompression.

Journal Of Neuroimaging. MRI Evidence of Non-Surgical Mechanical Reduction, Rehydration, and Repair of the Herniated Lumbar Disc.

http://www.tularespine.com/uploads/MRI_findings.pdf

Journal of Neurosurgery. The Effects of Vertebral Axial Decompression on Intradiscal Pressure.

http://www.tularespine.com/uploads/Effects_of_VAXD_on_ID_pressure.pdf

Vertebral Axial Decompression Therapy For Pain Associated with Herniated or Degenerated Discs or Facet Syndrome: An Outcome Study.

 http://www.tularespine.com/uploads/VAX_D_Research_Paper.pdf

Canadian Journal of Clinical Medicine. The Effects of Vertebral Axial Decompression on Sensory Nerve Dysfunction.

http://www.tularespine.com/uploads/Effects_of_VaxD_on_Sensory_Nerves.pdf

Emerging Technologies. Preliminary Findings. Decompression, Reduction and Stabilization of the Lumbar Spine: A Cost Effective Solution for Lumbosacral Pain.

http://www.tularespine.com/uploads/Emerging_Technologies.pdf

Clinical  Trial Study of a Non-Invasive Decompression System in the Treatment of Lumbosacral Radiculopathies.

http://www.tularespine.com/uploads/Clinical_Trial_for_DRS.pdf

Journal of Orthopedic & Sports Physical Therapy (Vol.35, No.1, January 2005)

Short and Long-term Outcomes Following Treatment with the Vax-D protocol for Patients with Chronic, Activity-limiting Low Back Pain.

OUTCOME: Significant improvements in a sample of patients with unfavorable prognosis due to chronic low back pain.

Journal of Neurologic Research (Vol. 29, No. 3, March 2003)

Efficacy of Vertebral Axial Decompression on Chronic Low Back Pain.

OUTCOME: This 144 patient study showed 76% achieved remission of pain. Except in emergent conditions, VaxX-D should be used on all conditions before surgery is undertaken.

Anesthesiology News, (Vol. 29, No. 3, March 2003)

Vax-D Reduces Chronic Discogenic Lo Back Pain-4 Year Study.

OUTCOME: Four year follow-up after Vax-D treatment shows a sustained 86% reduction in pain and that 91% of patients had resumed their normal activities.

Neurological Research Journal (Vol. 23, p. 706-714, October 2001)

Dermatosomal Somatosensory Evoked Potential Demonstration of Nerve Root Decompression after Vax-D Therapy.

OUTCOME: Pain reduction in the study group was 77% with successful decompression of the nerve roots at multiple levels.

Neurological Research Journal (Vol. 23, p. 780-784, October 2001)

A Prospective Randomized Controlled Study of Vax-D and Tens for the Treatment of Chronic Low Back Pain.

OUTCOME: A statistically significant reduction in pain and improvement in functional outcome was obtained in patients with chronic low back pain treated with Vax-D.

Canadian Journal of Clinical Medicine (Vol. 6, No. 1, January 1999)

An Overview of Vertebral Axial Decompression by Frank Tilaro, M.D.

OUTCOME: Vax-D is significantly capable of influencing sensory nerve function associated with a compressive radiculopathy. Complete remission was achieved by 64% of the study group.

Canadian Journal of Clinical Medicine (Vol. 5, No.1, January 1998)

The effects of Vax-D on sensory nerve function in Patients with Low Back Pain and Radiculopathy.

OUTCOME: The average pain reduction was 77%

Journal of Neurological Research (Vol. 20, No. 3, April 1998)

Vertebral Axial Decompression Therapy for Pain Associated with Herniated or Degenerative Discs or Facet Syndrome: An outcome Study of 778 Cases.

OUTCOME: The authors consider Vax-D to be a primary modality for low back pain, lumbar herniations at single and multiple levels, degenerative discs, and facet arthropathy, and decreased spinal mobility.

Journal of Neurosurgery (Vol. 81: 350-353, 1994)

Effects of Vertebral Axial Decompression on Intradiscal Pressure.

OUTCOME: Proof that Vax-D creates a negative intradiscal pressure force up to –160mmhg.

Neuropathy Research

Infrared Studies

Neuropathy Supportive Research